PSI is a leading global health organization with programs targeting malaria, child survival, HIV and reproductive health. Working in partnership within the public and private sectors, and harnessing the power of the markets, PSI provides life-saving products, clinical services and behavior change communications that empower the world's most vulnerable populations, in over 65 countries to lead healthier lives. Over 150 staff in the Washington D.C headquarters, 100 overseas expatriate staff and almost 8,000 local staff work to execute PSI's critical and innovative programs.
Health Impact and Donors
PSI has a unique focus on measurable health impact much like successful corporations measure profitability. By utilizing the DALY (Disability Adjusted Life Year) system, PSI estimates that in 2009 alone, its programs directly prevented more than 156,000 HIV infections, 2.6 million unintended pregnancies, almost 150,000 deaths from malaria and diarrhea and 19 million malaria episodes. In addition, roughly 25,000 patients were treated for TB.
With a focus on decentralized management and local experts, innovative programs and successful benchmarking, PSI is proud of its long term commitment to serve those most in need. PSI is supported by several major donors including: governments of the United States, United Kingdom, Germany and the Netherlands; the Global Fund, various United Nations agencies, private foundations, corporations and individuals.
PSI has HIV programs in over 60 countries around the world. Interventions, which include social marketing of HIV products and services and targeted HIV communications, are based upon a commitment to produce measurable health impact and an emphasis upon rigorous research and evaluation. Although condom social marketing and targeted communication remain the cornerstones of PSI's work to address the HIV pandemic, country programs also implement an increasingly comprehensive range of interventions in response to the changing needs of specific country contexts and populations. PSI is increasingly implementing innovations such as male circumcision services, targeted communication for concurrent sexual partnerships and injection drug use interventions.
Tuberculosis (TB) is a curable and preventable illness, yet it remains a major cause of death worldwide. It is one of the biggest killers of women of reproductive age and the most common cause of death among people living with HIV/AIDS. PSI provides a variety of innovative TB and TB/HIV-related services, engaging private providers in diagnosis and treatment and integrating HIV counseling and testing with TB services. It also creates innovative behavior change communications campaigns to increase awareness of TB and TB/HIV and to promote healthy behaviors.
PSI provides malaria control support to national Ministries of Health in over 30 countries worldwide. PSI tailors its malaria control programs to the unique environment in each country and the needs outlined by the Ministry of Health to achieve the Abuja Targets and MDGs. PSI's malaria control programs include delivery of insecticide treated mosquito nets, pre-packaged malaria treatment, behavior change communications and operational research.
In addition to these areas, PSI also focuses on child survival, reproductive health and safe water programs across country platforms.